Literature DB >> 8048164

Signaling by the cytokine receptor superfamily: JAKs and STATs.

J N Ihle1, B A Witthuhn, F W Quelle, K Yamamoto, W E Thierfelder, B Kreider, O Silvennoinen.   

Abstract

A variety of cytokines, lymphokines and growth factors function by interacting with receptors that are members of the cytokine receptor superfamily. These receptors share extracellular motifs and have limited similarity in their cytoplasmic domains. Although lacking catalytic domains, this family of receptors couples ligand binding with the induction of tyrosine phosphorylation. Recent studies have shown that this is mediated by members of the Janus kinase (JAK) family of cytoplasmic protein tyrosine kinases. JAKs physically associate with the membrane-proximal region of the ligand-bound receptor, leading to their tyrosine phosphorylation and activation. The activated JAKs phosphorylate the receptors as well as cytoplasmic proteins belonging to a family of transcription factors called the signal transducers and activators of transcription (STATs), providing a novel signaling pathway that is shared by all members of the cytokine receptor superfamily.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8048164     DOI: 10.1016/0968-0004(94)90026-4

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  132 in total

Review 1.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

2.  The signal transducer gp130: solution structure of the carboxy-terminal domain of the cytokine receptor homology region.

Authors:  T Kernebeck; S Pflanz; G Müller-Newen; G Kurapkat; R M Scheek; K Dijkstra; P C Heinrich; A Wollmer; S Grzesiek; J Grötzinger
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

Review 3.  Recombinant analogues of prolactin, growth hormone, and placental lactogen: correlations between physical structure, binding characteristics, and activity.

Authors:  A Gertler
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

4.  Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma.

Authors:  Lorraine Tracey; Raquel Villuendas; Pablo Ortiz; Ana Dopazo; Inmaculada Spiteri; Luis Lombardia; Jose L Rodríguez-Peralto; Jesús Fernández-Herrera; Almudena Hernández; Javier Fraga; Orlando Dominguez; Javier Herrero; Miguel A Alonso; Joaquin Dopazo; Miguel A Piris
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  Inhibitory effects of interleukin-10 on synovial cells of rheumatoid arthritis.

Authors:  A Kawakami; K Eguchi; N Matsuoka; M Tsuboi; S Urayama; Y Kawabe; T Aoyagi; K Maeda; S Nagataki
Journal:  Immunology       Date:  1997-06       Impact factor: 7.397

6.  Effects of hepatocyte nuclear factor-4alpha on the regulation of the hepatic acute phase response.

Authors:  Zhongyan Wang; Peter A Burke
Journal:  J Mol Biol       Date:  2007-05-24       Impact factor: 5.469

7.  The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis.

Authors:  R Shaknovich; P L Yeyati; S Ivins; A Melnick; C Lempert; S Waxman; A Zelent; J D Licht
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

8.  Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes.

Authors:  K C Gilmour; R Pine; N C Reich
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex.

Authors:  S N Constantinescu; E Croze; A Murti; C Wang; L Basu; D Hollander; D Russell-Harde; M Betts; V Garcia-Martinez; J E Mullersman; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

10.  Ligand-dependent and -independent activation of the transcription factor gamma RF-1 in a cell-free system.

Authors:  C A Feghali; T M Wright
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.